Cancer HealthCast: New Technologies Lead to Major Breakthroughs in Cancer Detection, Screening at NCI
Two key programs are playing a vital role in detecting and diagnosing cancer as well as reducing the overall burden on patients and their families.
The National Cancer Institute is utilizing a host of new technologies to diagnose and detect cancer thanks to its Innovative Molecular Analysis Technologies (IMAT) and Informatics Technology for Cancer Research (ITCR) programs. These programs are developing methods that are enhancing cancer research, including artificial intelligence.
Dr. Kelly Crotty, program director for NCI’s Center for Strategic Scientific Initiatives, said not only have the programs helped researchers better identify and screen for cancer, but also they’ve been instrumental in driving progress in clinical care. Crotty also shares updates about NCI’s Liquid Biopsy Consortium and discusses the benefits and challenges she’s seeing with AI.
-
Dr. Kelly Crotty Program Director, Center for Strategic Scientific Initiatives NCI
-
Trump Rescinds Biden AI EO, Shifts Development to Private Sector
The president signaled this week that the White House will center industry responsibility for AI leadership.
3m read -
AI FedLab
The Defense IT Summit will bring together federal and industry leaders to discuss AI in defense operations, CJADC2 and multi and hybrid cloud security.
Carahsoft Conference & Collaboration Center | 11493 Sunset Hills Rd. Reston, VA 20190 -
Digitizing Records for an AI-Driven Future
CMS and NARA are digitizing and standardizing data to enable AI, while also developing effective governance strategies to manage associated risks.
30m watch -
The Year Ahead: FBI’s 2025 Cybersecurity Priorities
The FBI is increasing awareness of vulnerabilities and employing AI-enabled tools to secure networks from sophisticated cyber threats.
19m listen
